Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. [electronic resource]
Producer: 20190314Description: 834-844 p. digitalISSN:- 1873-7560
- Abiraterone Acetate -- administration & dosage
- Androgen Antagonists -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Docetaxel -- administration & dosage
- Humans
- Male
- Neoplasm Metastasis
- Network Meta-Analysis
- Prostatic Neoplasms -- pathology
- Randomized Controlled Trials as Topic
- Risk Factors
- Survival Rate
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.